X-act Cologne Clinical Research GmbHClinical researchData-driven excellence: the cornerstone of clinical researchEssential areas such as study planning, interpretation, regulatory guidance, and key study design decisions remain human responsibilities, although AI increasingly supports routine tasks. X-act gets … more ➔
Die Hoffotografen GmbHCell therapySolid tumours meet their matchSolid tumours pose major obstacles for cell therapies, but German-American biotech T-knife is tackling them head-on. CEO Tom Soloway and CTO Elisa Kieback share how their “supercharged” TCR-Ts are … more ➔
Boehmert & BoehmertRegulationUS-policy-made challenges for the bio-pharma sectorNew developments under the current U.S. administration may be a challenge for the pharma/biotech industry: the Inflation Reduction Act, Orange Book Challenges, Most Favored Nation Policy, and the new … more ➔
AseBio BioSpain 2025Opportunity Health SL wins start-up pitch contestOut of 43 pitches, the founders of Spanish Opportunity Health S.L. delivered the best presentation for a new life sciences product: a choking device that can potentially be used by anyone in emergency … more ➔
AseBioBioSpain 2025 Panel discussion: what drives US investments?Alongside a start-up pitch featuring 45 international participants, the second day of BioSpain 2025 (7–9 October 2025, Barcelona) offered biotech start-ups a panel discussion with prominent US investors, … more ➔
https://www.chimia.ch/chimia/article/view/2025_292BiomanufacturingBiomanufacturing in SwitzerlandSwitzerland is a key hub for biomanufacturing, with immunological products like antibodies and vaccines making up 18.5% of 2024 exports. Swiss companies drive biotech innovation and biocatalysis across … more ➔
AseBioBioSpain 2025Spain again tops Europe in clinical trialsSpain has once again secured the top position in Europe for clinical trials. According to various Clinical Research Organisations at BioSpain 2025 (7–9 October, Barcelona), this is largely due to the … more ➔
Kinga Lubowiecka/ EMBLResearch InfrastructureEMBL and BIS: Advancing Biological ImagingThe EMBL Imaging Centre has received €7 million in support from Boehringer Ingelheim Stiftung to further advance its cutting-edge imaging technologies. more ➔
SPRINDDeeptech bioeconomyIt is time to rethink biotech scalingBiomanufacturing promises domestic, sustainable, sovereign and resilient production. Capacities are trapped in outdated scale-up processes. SPRIND urges investment and disruptive innovation to propel … more ➔
Chemspec Europe 2025Fine and speciality chemicals industry keeps its coolResilience and quality connections define Chemspec Europe 2025. more ➔
X-act Cologne Clinical Research GmbH
Die Hoffotografen GmbH
Boehmert & Boehmert
AseBio 
AseBio
https://www.chimia.ch/chimia/article/view/2025_292
AseBio
Kinga Lubowiecka/ EMBL
SPRIND
